Skip to content
Medical Health Aged Care

Feedback invited from in-home aged care stakeholders to inform pricing advice

IHACPA 2 mins read

The Independent Health and Aged Care Pricing Authority (IHACPA) today released its Consultation Paper on the Pricing Approach for the Support at Home Service List 2025–26.

The Australian Government’s Support at Home program will combine existing in-home aged care services into a single, simplified program designed to assist older people to live independently at home for longer with the support services they require.

The Support at Home program will replace the Home Care Packages Program and Short-‑Term Restorative Care Programme from 1 July 2025. 

To support the development of independent in-home aged care pricing and costing advice to the government, IHACPA is seeking input on the proposed approach, methodology and principles to underpin this advice.

All stakeholders are invited to provide their feedback to help shape the development of IHACPA’s Support at Home pricing advice for 2025–26.

The consultation period is open to the public until 5pm AEDT 25 October 2024.

This year, IHACPA is seeking input on pricing policy principles, improvements to the representativeness of the cost collections, price benchmarking, methodology and adjustments, and priorities for future developments.

The consultation provides an opportunity for the aged care community, including older people living at home, their representatives and families, carers, aged care providers, governments, people working in aged care, and peak bodies, to provide their input on the factors that should be taken into consideration when developing pricing advice. This will support greater alignment of funding to the costs of delivering care.

The Pricing Authority Chair, Mr David Tune AO PSM said, ‘We want to listen to the issues that are important to the sector to build our understanding and ensure our advice results in the most accurate and fair pricing that reflects the true cost of delivering safe and quality in-home aged care services.’

‘Input from the aged care community will ensure our advice is representative of the diversity of aged care services, and meets the unique needs and challenges faced by in-home care recipients and providers,’ said Mr David Tune AO PSM.

As more information on the cost of delivering services becomes available, including through ongoing research and the input of stakeholders, IHACPA will refine its pricing advice and investigate future priorities.

The Department of Health and Aged Care will remain the system operators with overall responsibility for aged care policy, including the funding of in-home support services.

For media enquiries: contact communications.ihacpa@ihacpa.gov.au

More from this category

  • Agriculture Farming Rural, Medical Health Aged Care
  • 08/11/2024
  • 15:01
Council of Presidents of Medical Colleges

CPMC Warns AHPRA’s Plan Won’t Fix Doctor Shortages in Regional Areas and Key Specialties

Following the release of the Unleashing the Potential of our Health Workforce Report, the Council of Presidents of Medical Colleges (CPMC) has again warned that fast-tracking International Medical Graduate registration alone will not solve Australia's rural healthcare challenges. Without proper planning, new specialists may concentrate in urban areas while regional communities continue to face specialist shortages. "We are reviewing the broader health workforce reform agenda outlined in the Scope of Practice Review and will consider the recommendations in the context of all the current health workforce reforms. We cannot accept an implementation approach for international medical registration that fails to…

  • Government Federal, Medical Health Aged Care
  • 08/11/2024
  • 06:30
Immunisation Foundation of Australia

Whooping cough outbreak worst on record

Whooping cough outbreak worst on record More than 45,000 cases of the infectious lung disease expected by year end Australia is in the grip…

  • Contains:
  • Medical Health Aged Care
  • 07/11/2024
  • 23:11
Zenas BioPharma

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the Company’s participation at the following healthcare investor conferences:Guggenheim’s Inaugural Healthcare Innovation Conference on November 12, 2024, in Boston, MAJefferies London Healthcare Conference on November 19, 2024 presentation at 4:00 p.m. to 4:25 p.m. GDT, in LondonCiti’s 2024 Global Healthcare Conference on December 3, 2024 presentation at 9:30 a.m. to 10:10 a.m. ET, in Miami, FLEvercore ISI HealthCONx Conference on December 4,…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.